Please ensure Javascript is enabled for purposes of website accessibility

PBS and NPR Mount Last-Ditch Fight to Save Federal Funding

2 hours ago

Netanyahu Under Mounting Political Pressure After Party Quits

2 hours ago

Wall Street Opens Higher After Inflation, Bank Results

3 hours ago

Sick of Loud Ads on Netflix? A Proposed California Law Turns Down the Volume

22 hours ago

Record Numbers of Americans Say Immigration Is Good for Country: Gallup Poll

24 hours ago

In California Strawberry Fields, Immigration Raids Sow Fear

1 day ago

Newsom’s Office Attacks Stephen Miller, Calling Him a ‘Fascist Cuck’

1 day ago

Trump’s Spending Bill Will Likely Boost Costs for Insurers, Shrink Medicaid Coverage

1 day ago
First Over-the-Counter Birth Control Pill Gets Federal Approval
gvw_ap_news
By Associated Press
Published 2 years ago on
July 13, 2023

Share

U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from the same aisle as aspirin and eyedrops.

The Food and Drug Administration said Thursday it cleared Perrigo’s once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter. The company won’t start shipping the pill until early next year, and there will be no age restrictions on sales.

Hormone-based pills have long been the most common form of birth control in the U.S., used by tens of millions of women since the 1960s. Until now, all of them required a prescription.

Medical societies and women’s health groups have pushed for wider access, noting that an estimated 45% of the 6 million annual pregnancies in the U.S. are unintended. Teens and girls, women of color and those with low incomes report greater hurdles in getting prescriptions and picking them up.

Some of the challenges can include paying for a doctor’s visit, getting time off from work and finding child care.

“This is really a transformation in access to contraceptive care,” said Kelly Blanchard, president of Ibis Reproductive Health, a non-profit group that supported the approval. “Hopefully this will help people overcome those barriers that exist now.”

Ireland-based Perrigo did not announce a price. Over-the-counter medicines are generally much cheaper than prescriptions, but they aren’t covered by insurance.

Many common medications have made the switch to non-prescription status in recent decades, including drugs for pain, heartburn and allergies.

Perrigo submitted years of research to FDA to show that women could understand and follow instructions for using the pill. Thursday’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain underlying medical conditions would understand they shouldn’t take the drug.

FDA’s action only applies to Opill. It’s in an older class of contraceptives, sometimes called minipills, that contain a single synthetic hormone and generally carry fewer side effects than more popular combination hormone pills.

But women’s health advocates hope the decision will pave the way for more over-the-counter birth control options and, eventually, for abortion pills to do the same.

Approval Process Pre-Dates Abortion Ruling

That said, FDA’s decision has no relation to the ongoing court battles over the abortion pill mifepristone. The studies in Perrigo’s FDA application began years before the Supreme Court’s reversal of Roe v. Wade, which has upended abortion access across the U.S.

With some states curtailing women’s reproductive rights, the FDA has faced pressure from Democratic politicians, health advocates and medical professionals to ease access to birth control. The American Medical Association and the leading professional society for obstetricians and gynecologists backed Opill’s application for over-the-counter status.

An outside panel of FDA advisers unanimously voted in favor of the switch at a hearing in May where dozens of public speakers called for Opill’s approval.

Dyvia Huitron was among those who presented, explaining how she has been unable to get prescription birth control more than three years after becoming sexually active. The 19-year-old University of Alabama student said she still isn’t comfortable getting a prescription because the school’s health system reports medical exams and medications to parents.

“My parents did not let me go on the pill,” Huitron said in a recent interview. “There was just a lot of cultural stigma around being sexually active before you’re married.”

While she uses other forms of contraception, “I would have much preferred to have birth control and use these additional methods to ensure that I was being as safe as possible.”

Huitron spoke on behalf of Advocates for Youth, one of the dozens of groups that have pushed to make prescription contraceptives more accessible.

The groups helped fund some of the studies submitted for Opill and they encouraged HRA Pharma, later acquired by Perrigo, to file its application with the FDA.

Advocates were particularly interested in Opill because it raised fewer safety concerns. The pill was first approved in the U.S. five decades ago but hasn’t been marketed here since 2005.

“It’s been around a long time and we have a large amount of data supporting that this pill is safe and effective for over-the-counter use,” said Blanchard, of Ibsis Reproductive Health.

Newer birth control pills typically combine two hormones, estrogen and progestin, which can help make periods lighter and more regular. But their use carries a heightened risk of blood clots and they shouldn’t be used by women at risk for heart problems, such as those who smoke and are over 35.

Opill has only progestin, which prevents pregnancy by blocking sperm from reaching the cervix. It must be taken around the same time daily to be most effective.

In its internal review published in May, the FDA noted that some women in Perrigo’s study had trouble understanding the drug’s labeling information. In particular, the instructions warn that women with a history of breast cancer should not take the pill because it could spur tumor growth. And women who have unusual vaginal bleeding are instructed to talk to a doctor first, because it could indicate a medical problem.

Perrigo executives said the company will spend the rest of the year manufacturing the pill and its packaging so it can be available in stores nationwide and online by early next year.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Max Fire Near Pine Flat Lake Grows to 426 Acres. Evacuations Remain in Place

DON'T MISS

Vendors Demand Arias Resign Over False ICE Raid Warning. He Says Trump Is the Culprit

DON'T MISS

Fresno Unified Rewards Incompetence? Ex-Comms Chief Could Get Huge Severance

DON'T MISS

Elmo’s X Account Gets Hacked, Posts Antisemitic and Racist Messages

DON'T MISS

3-Year-Old Dies After Drowning in Backyard Pool in Porterville

DON'T MISS

Meta Investors, Zuckerberg to Square off at $8 Billion Trial Over Alleged Privacy Violations

DON'T MISS

MAGA Is Tearing Itself Apart Over Jeffrey Epstein

DON'T MISS

Fresno Grass Fire Burns Along Veterans Boulevard, Under Investigation

DON'T MISS

Trump to Unveil $70 Billion in AI and Energy Investments

DON'T MISS

Fire at Boston-Area Senior Living Facility Kills at Least Nine

UP NEXT

US Judge Grants Trump Admin Request to Scrap Biden-Era Medical Debt Rule

UP NEXT

Madera Hospital in Full Swing With New Permanent CEO

UP NEXT

Higher Premiums and Lost Coverage: How Trump’s Budget Will Change Health Care in California

UP NEXT

Trump Says Pharmaceutical Tariffs Could Reach 200%

UP NEXT

Judge Orders CVS’ Omnicare Unit to Pay $949 Million Over Invalid Prescriptions

UP NEXT

TSA Set to Let Airport Travelers Keep Their Shoes on, Media Reports Say

UP NEXT

Space Industry Urges Congress Not to Axe System That Prevents Satellite Collisions

UP NEXT

Kaweah Health Names Its New Chief Nurse. She’s From Texas

UP NEXT

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

UP NEXT

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

PBS and NPR Mount Last-Ditch Fight to Save Federal Funding

2 hours ago

Netanyahu Under Mounting Political Pressure After Party Quits

2 hours ago

Fresno County Budget: Supes Talk How ‘Big Beautiful Bill’ Will Cut SNAP, Medi-Cal

2 hours ago

US Strikes Trade Deal With Indonesia, Trump Says, Without Providing Details

3 hours ago

Wall Street Opens Higher After Inflation, Bank Results

3 hours ago

Heinous, Heartbreaking, Expensive: California Schools Face Avalanche of Sex Abuse Claims

3 hours ago

Israel Strikes Syrian City, Vows to Protect Druze From Government Forces

3 hours ago

Max Fire Near Pine Flat Lake Grows to 426 Acres. Evacuations Remain in Place

17 hours ago

Vendors Demand Arias Resign Over False ICE Raid Warning. He Says Trump Is the Culprit

18 hours ago

Fresno Unified Rewards Incompetence? Ex-Comms Chief Could Get Huge Severance

19 hours ago

Teen Girl Suspect in Caleb Quick Killing Returns to Court. Will She Be Tried as Adult?

The 16-year-old girl accused of acting as the getaway driver in the murder of Caleb Quick appeared in court Tuesday morning. During a June 1...

14 minutes ago

14 minutes ago

Teen Girl Suspect in Caleb Quick Killing Returns to Court. Will She Be Tried as Adult?

27 minutes ago

Visalia Basketball Coach Dies While Hiking in Sequoia National Park

2 hours ago

Fresno Police to Target Dangerous Driving Behaviors in Safety Operation

Portrait of Paula Kerger, the chief executive of PBS.
2 hours ago

PBS and NPR Mount Last-Ditch Fight to Save Federal Funding

Members of Knesset, Israel's parliament, attend a meeting in Jerusalem, March 27, 2023. (Reuters File)
2 hours ago

Netanyahu Under Mounting Political Pressure After Party Quits

2 hours ago

Fresno County Budget: Supes Talk How ‘Big Beautiful Bill’ Will Cut SNAP, Medi-Cal

President Donald Trump speaks to the media after the U.S. Supreme Court dealt a blow to the power of federal judges by restricting their ability to grant broad legal relief in cases as the justices acted in a legal fight over Trump's bid to limit birthright citizenship, in the Press Briefing Room at the White House in Washington D.C., June 27, 2025. (Reuters File)
3 hours ago

US Strikes Trade Deal With Indonesia, Trump Says, Without Providing Details

Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., March 19, 2020. (Reuters File)
3 hours ago

Wall Street Opens Higher After Inflation, Bank Results

Help continue the work that gets you the news that matters most.

Search

Send this to a friend